newsfilter
← Latest News
GlobeNewswire·

Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel

CARLSBAD, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:QLGN) (the "Company") today announced that on September 11, 2024, the Company received a notice from Nasdaq indicating that the